DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00061360 (ClinicalTrials.gov)	June 26, 2003	23/5/2003	Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia	A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects With Severe Aplastic Anemia	Severe Aplastic Anemia	Drug: ATG+Rapamune+cyclosporine;Drug: ATG+cyclosporine	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Completed	2 Years	110 Years	All	77	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00061360
(ClinicalTrials.gov)

June 26, 2003

23/5/2003

Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects With Severe Aplastic Anemia

Severe Aplastic Anemia

Drug: ATG+Rapamune+cyclosporine;Drug: ATG+cyclosporine

National Heart, Lung, and Blood Institute (NHLBI)

NULL

Completed

2 Years

110 Years

All

Phase 2

United States